Deepa Pakianathan
InvestorGeneral Partner at Delphi Ventures
San Francisco Bay Area
Writes $50K – $5M checks
Find your path to Deepa
233 people in our graph share verified history with Deepa — schools, employers, funds. One of them is your warm intro.
Zachary BogueunlockedDeepa: together at Freenome (2021–2026)
×3Deepa: together at Genentech
Deepa: together at Theravance Biopharma
×7Deepa: together at Wake Forest University
About
Deepa Pakianathan leads all biotech investing while serving as CEO and founder of a stealth oncology company, combining active operator experience, recognized expertise in immuno-oncology ADC design, and high-level policy engagement.
Invests in
BiotechHealthtechMedical Devices
Experience
- Stealth Oncology CompanyCEO and co-foundercurrent2023 — present
- FreenomeIndependent board membercurrent2021 — present
- Delphi VenturesGeneral Partnercurrent2001 — presentSan Francisco Bay Area
- Palleon PharmaceuticalsLead Director and Independent board membercurrent2020 — present
- Theravance Biopharma US, Inc.Independent Board Membercurrent2020 — presentCommittees: Chair of N&G, Member of Audit and Development and Commercialization
- Karyopharm Therapeutics Inc.Independent Board Membercurrent2011 — presentCommittees: Chair of Compensation and member of Audit and Development and Commercialization
- Mereo BioPharmaIndependent Board Membercurrent2019 — presentChair of Audit and member of Remuneration committee
- Calithera BiosciencesLead Director and Independent Board Member2010 — 2023Lead director, Chair of N&G
- J.P. MorganVice President1998 — 2001
- Genesis Merchant Group SecuritiesResearch Analyst1997 — 1998San Francisco Bay Area
- GenentechPost-doctoral scientist1993 — 1997SSF, CA
Skills & more
Business StrategyMergers & AcquisitionsVenture CapitalEntrepreneurshipInvestment BankingLife Sciences1Biotechnology1Biotech investor1Public biotech Company board director
From Deepa's professional profile.
Colleagues at Delphi Ventures
Frequently asked questions
- Who is Deepa Pakianathan?
- Deepa Pakianathan leads all biotech investing while serving as CEO and founder of a stealth oncology company, combining active operator experience, recognized expertise in immuno-oncology ADC design, and high-level policy engagement.
- Where does Deepa Pakianathan work?
- Deepa Pakianathan is General Partner at Delphi Ventures.
- What does Deepa Pakianathan invest in?
- Deepa Pakianathan invests in Biotech, Healthtech, Medical Devices.
- What check size does Deepa Pakianathan write?
- Deepa Pakianathan typically writes checks of $50K – $5M.
- Where did Deepa Pakianathan go to school?
- Deepa Pakianathan studied at Wake Forest University (Doctor of Philosophy - PhD, Immunology and Immunoparasitology); Wake Forest University (Master of Science - MS, Immunology).
Same school
Also attended Wake Forest University141
Daniel van der MerweSenior Director at JMI EquityNash Carey-EwendSenior Associate, Echo Health Advisors at Echo Health VenturesAndrew McGuirkVenture Fellow at Moneta VenturesEliza CushmanPartner at Congruent VenturesBrett BrohlManaging Partner at Bread And Butter Ventures, LlcJeff BaldwinPrincipal at TCV
+ 135 more
Shared employers
Also worked at Palleon Pharmaceuticals7
Katarina PancePrincipal at SR One Capital ManagementNikolaInvestment Committee Member at ACF InvestorsNikola TrbovicManaging Partner at SV Health InvestorsLori HuManaging Director at Vertex Ventures HCDr. Jens EcksteinAdvisor at Apollo Health VenturesRoss LeimbergFounder / EIR at 82VS
+ 1 more
Also worked at Karyopharm Therapeutics Inc.3
Also worked at Calithera Biosciences1
Also worked at J.P. Morgan1,289
Cat WuInvestor at Index VenturesRishi ModiInvestor at GV (Google Ventures)Akshat GoenkaInvestor at Moonfire VenturesNaseem MoumeneVice President at Northzone, investing across complex and fragmented industries undergoing fundamental shiftsFranklin BiGeneral Partner at Pantera CapitalMegan LightcapPartner, Creator Fund at Slow Ventures
+ 1,283 more